News
Filter by year:
-
Concerto Biosciences Signs Development and Commercialization Agreement with Sacco System to Advance Next-Generation Microbial Ingredient Discovery
-
UNISERS Ships First Fully-Automated Fab Tool and Strengthens Leadership to Scale In-Fab Deployment
-
SEEQC and Allegro Merger Corp. Enter Into Merger Agreement
-
Nouscom Highlights Potential of NOUS-209 to Intercept Cancer in Lynch Syndrome Carriers in Seminal Nature Medicine Publication
-
Altoida and Mindspan Announce Research Collaboration to Use AI/AR-Powered Digital Cognitive Assessment to Personalize Cognitive Care
-
Iktos named Top BioTech and Life Sciences Companies of 2025
-
Iktos Enters Strategic €1B+ Multi-Target AI Partnership with Servier to Advance Drug Discovery in Oncology and Neurology
-
Pierre Fabre Laboratories and Iktos announce Integrated Drug Discovery Collaboration
-
DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies
-
M Ventures: Pharma CVC and biotech innovation in 2026
-
NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s
